2025 Agenda

Conference Overview - More to Come Soon!

*Schedule is tentative and is subject to change.

Cellular Therapies and Novel Blood Products in Trauma and Critical Care – The Future of Transfusion Medicine

Sunday, May 4

Registration Desk Open
4:00 pm – 7:00 pm
Welcome Reception
6:30 pm – 8:00 pm

Monday, May 5

7:30 am – 6:00 pm – Innovations in Transfusion Medicine and Cellular Therapeutics: Enhancing Outcomes in Trauma and Critical Care
On Day 2, discussions will focus on the intersection of transfusion medicine and regenerative medicine, highlighting advancements in blood-derived therapeutics, cellular therapies, and innovative regenerative products for treating acute and chronic conditions linked to trauma and critical illness. The design of clinical trials in trauma will also be addressed. Attendees will gain valuable insights into how these innovations can significantly improve patient outcomes.

6:30 – 9 pm Reception – Kasbah Patio
Dinner – Cortijo Plaza

Tuesday, May 6

7:30 am – 6:30 pm | Novel Blood Products, Stem Cell-Derived Blood, Military Health Session
On Day 3, talk topics will delve into stem cell-derived blood components and innovative blood products aimed at providing new therapies for trauma and critical care. We’ll explore recent findings related to plasma-based treatments for conditions such as sepsis, traumatic brain injury, and burns. Additionally, we’ll address the regulatory challenges faced in approving these novel products. The day will wrap up with a session on military health, concentrated on optimizing care, identifying gaps in research optimizing the care of injured warfighters on the battlefield or pre-Role 2 care with three main topic areas that will be discussed: 1) management of hemorrhage on the battlefield with novel blood products and therapeutics, 2) management of organ failure on the battlefield, and 3) management of TBI and head wounds on the battlefield. A fourth topic on wound management and infection will be covered in a focus group discussion on May 7th. Specific points for discussion will include 1) novel products and technologies, 2) point-of-care devices and diagnostics, and 3) logistics, feasibility, and transport.

6:30 – 9 pm Reception – Valencia Lawn
Dinner – Valencia Lawn

Wednesday, May 7

8:00 – 12:30 pm | Cell and Gene Editing of Stem Cell and Blood Products, Funding Panel and Round Table Discussions
On Day 4, discussions will focus on exciting advancements in cell and gene editing, as well as the potential for scaling up the production of enhanced, personalized blood and cell therapies for trauma and critical care patients. We’ll also tackle the regulatory challenges involved in getting these innovative products approved with a panel discussion. The day will conclude with a stakeholder session by major funders of research in this field.

1:30 – 4:30 pm  | Focus Group Discussions: After lunch, we’ll host two sequential focus group discussions.

Focus group 1: Next-Generation Solutions for Wound Healing and Tissue Regeneration
Focus Group 2: From Battlefield to Bedside: Overcoming Challenges in Developing a Dried Plasma Product for Military and Civilian Use
The aim of these two focus groups is to foster collaborative dialogue and reach a consensus on key topics, including 1) Research and development priorities, 2) Regulatory challenges, and 3) Commercialization obstacles. Key individuals with expertise in these areas will be invited to participate including regulatory insight from the FDA and funding agency input. These discussions will help shape strategic directions and actionable plans for advancing innovation in these critical areas.

4:30 pm Conference Adjourn

Presented by the UCSF Department of Laboratory Medicine and UCSF Center for Research in Transfusion Medicine and Cellular Therapies

Co-hosted by Colorado State University and the Armed Forces Institute of Regenerative Medicine

SIGNUP FOR MORE INFORMATION

Questions? Email us at [email protected] or call 303-238-0685